- Home
- WINT vs ELWS Comparison
WINT vs ELWS Comparison
Compare WINT & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- ELWS
- Stock Information
- Founded
- WINT 1992
- ELWS 2018
- Country
- WINT United States
- ELWS Japan
- Employees
- WINT N/A
- ELWS N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- ELWS
- Sector
- WINT Health Care
- ELWS
- Exchange
- WINT Nasdaq
- ELWS Nasdaq
- Market Cap
- WINT 5.3M
- ELWS 6.2M
- IPO Year
- WINT 1995
- ELWS 2023
- Fundamental
- Price
- WINT $0.50
- ELWS $2.66
- Analyst Decision
- WINT Hold
- ELWS
- Analyst Count
- WINT 1
- ELWS 0
- Target Price
- WINT $18.00
- ELWS N/A
- AVG Volume (30 Days)
- WINT 549.5K
- ELWS 914.3K
- Earning Date
- WINT 11-26-2024
- ELWS 12-03-2024
- Dividend Yield
- WINT N/A
- ELWS N/A
- EPS Growth
- WINT N/A
- ELWS N/A
- EPS
- WINT N/A
- ELWS N/A
- Revenue
- WINT N/A
- ELWS $1,139,113.00
- Revenue This Year
- WINT N/A
- ELWS N/A
- Revenue Next Year
- WINT N/A
- ELWS N/A
- P/E Ratio
- WINT N/A
- ELWS N/A
- Revenue Growth
- WINT N/A
- ELWS 285.14
- 52 Week Low
- WINT $0.45
- ELWS $1.04
- 52 Week High
- WINT $22.32
- ELWS $13.00
- Technical
- Relative Strength Index (RSI)
- WINT 27.72
- ELWS 46.34
- Support Level
- WINT $0.45
- ELWS $2.56
- Resistance Level
- WINT $0.64
- ELWS $3.33
- Average True Range (ATR)
- WINT 0.06
- ELWS 1.01
- MACD
- WINT 0.07
- ELWS -0.18
- Stochastic Oscillator
- WINT 19.50
- ELWS 1.77
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.